We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Search results

Order by: most recent most popular relevance



Results: 1-10 of 59

Cosmetics, personal care products purportedly linked to kids’ allergies
  • Shook Hardy & Bacon LLP
  • India
  • November 20 2014

A small study of households in India has purportedly associated higher levels of indoor pollutants, including household products, such as cosmetics


India prohibits imports of cosmetics tested on animals
  • Shook Hardy & Bacon LLP
  • India
  • October 23 2014

Beginning November 13, 2014, India will no longer permit the "import of cosmetics tested on animals." The government reportedly took the action some


Dietary Supplement & Cosmetics Legal Bulletin: January 2017
  • Shook Hardy & Bacon LLP
  • India, USA
  • January 19 2017

In December, the U.S. Food and Drug Administration (FDA) announced that it will make publicly available certain data received through the Center for


India’s guidance for biosimilar drugs draws cautious industry welcome
  • Shook Hardy & Bacon LLP
  • India
  • September 20 2012

According to a news source, industry has given India’s new guidelines for biosimilar drugs, launched August 15, 2012, a “cautious welcome.”


Indian state seizes Red Bull, caffeine content above legal limits
  • Shook Hardy & Bacon LLP
  • India
  • April 6 2012

The Maharashtra Food and Drug Administration (MFDA) has reportedly seized more than 1 million cans of Red Bull, an energy drink containing 250-300 parts per million (ppm) of caffeine, on the ground that the product exceeds the 145 ppm limit for carbonated beverages


Indian drug industry disputes prohibition on brand names
  • Shook Hardy & Bacon LLP
  • India
  • November 1 2012

According to a news source, the Indian Drugs Manufacturing Association is gearing up to challenge action taken by the country’s drug controller to prevent the sale of medicines under brand names as part of an effort to accelerate sales of less-expensive generics


Scientists oppose SCI’s recommended moratorium on biotech crops
  • Shook Hardy & Bacon LLP
  • India
  • November 1 2012

After an expert committee appointed by the Supreme Court of India (SCI) recommended halting field trials of transgenic food crops for 10 years, biotechnologists, agricultural scientists and agribiotech-industry heads reportedly gathered in Bangalore to oppose the recommendations


WTO rejects Indian restrictions on U.S. poultry imports
  • Shook Hardy & Bacon LLP
  • India, USA
  • October 17 2014

A World Trade Organization (WTO) dispute settlement panel has found that a series of food safety restrictions imposed by the Indian government on


Fake cosmetics-manufacturing facilities sealed in Bangladesh; truckloads of goods destroyed
  • Shook Hardy & Bacon LLP
  • India, USA
  • July 10 2014

According to news sources, a mobile court that is part of a Rapid Action Battalion in Bangladesh recently conducted a raid that resulted in the


Ranbaxy loses FDA approval for two generics
  • Shook Hardy & Bacon LLP
  • India, USA
  • November 13 2014

According to a statement that Ranbaxy Laboratories Ltd. provided to the Bombay Stock Exchange Website, the U.S. Food and Drug Administration (FDA